Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Approved Nearly 75 Years Ago, Bufferin NDA On Withdrawal Notice Due To Registration Lapse
US FDA Recordkeeping Change Doesn't Affect Monograph Bufferin And Equivalents
Nov 27 2022
•
By
Malcolm Spicer
• Source: Shutterstock
More from Regulation
More from Policy & Regulation